| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.0088 | 0.9 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |